Hoover Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$1.15M Buy
14,820
+1,782
+14% +$133K 0.21% 48
2021
Q1
$964K Sell
13,038
-661
-5% -$48.8K 0.18% 52
2020
Q4
$1.07M Buy
13,699
+775
+6% +$59.3K 0.27% 34
2020
Q3
$1.02M Buy
12,924
+2,943
+29% +$231K 0.34% 30
2020
Q2
$736K Buy
9,981
+38
+0.4% +$2.86K 0.28% 36
2020
Q1
$730K Hold
9,943
0.4% 29
2019
Q4
$863K Buy
9,943
+372
+4% +$30.6K 0.42% 30
2019
Q3
$769K Buy
9,571
+4
+0% +$321 0.68% 18
2019
Q2
$765K Buy
9,567
+4
+0% +$306 0.7% 18
2019
Q1
$759K Buy
9,563
+5
+0.1% +$374 0.72% 18
2018
Q4
$697K Buy
+9,558
New +$675K 0.77% 18

Other funds holding MRK

Hoover Financial Advisors's MRK Position: Q2 2021 in Review

Hoover Financial Advisors increased its Merck (MRK) stake by 14% in Q2 2021, buying an estimated $133K and bringing the position to 14,820 shares worth $1.15M. The position accounts for 0.21% of the portfolio, ranked #48.

Hoover Financial Advisors first reported a position in MRK in Q4 2018 and has held it in 11 quarters since. 2,673 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • Hoover Financial Advisors held 14,820 shares of Merck worth $1.15M as of Q2 2021.
  • Hoover Financial Advisors bought 1,782 Merck shares in Q2 2021, an estimated $133K.
  • Merck made up 0.21% of Hoover Financial Advisors's portfolio in Q2 2021, its #48 holding.
  • Hoover Financial Advisors first reported a position in Merck in Q4 2018 and has held it in 11 quarters since.
  • 2,673 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.